Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Prostate Cancer (Diagnosis): early-phase trial registry
5 of 6 indexed Prostate Cancer (Diagnosis) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Prostate Cancer (Diagnosis): 6 US clinical trials tracked, 5 recruiting.
Prostate Cancer (Diagnosis) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Karolinska Institutet, running 1 of these trials.
Enrollment posture brief
Registry condition prostate-cancer-diagnosis
OPEN 5 | RECR 83% | LATE 0 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Prostate Cancer (Diagnosis) lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Prostate Cancer (Diagnosis) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Prostate Cancer (Diagnosis) is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Prostate Cancer (Diagnosis) research.
Karolinska Institutet accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Prostate Cancer (Diagnosis) enrolment sits around 300 participants.
Median target enrolment is 300 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Prostate Cancer (Diagnosis) splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
NYU Langone Health
NCT06559059
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Duke University
NCT07144228
PSMA PET for Surveillance After Focal Therapy
University of Chicago
NCT07115914
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Johns Hopkins University
NCT07271017
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Thomas Hope
NCT07054346
Stockholm3 Validation Study in a Multi-Ethnic Cohort
Karolinska Institutet
NCT04583072
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Prostate Cancer (Diagnosis) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Prostate Cancer (Diagnosis) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Prostate Cancer (Diagnosis) page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Prostate Cancer (Diagnosis) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Karolinska Institutet sponsors the most Prostate Cancer (Diagnosis) trials on record, review their full trial history before evaluating a specific study. See Karolinska Institutet's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prostate Cancer (Diagnosis) condition card totals 6 registered trials; most-linked intervention The Stockholm3 test; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.